IE00BTN1Y115
© PR Newswire
04.12.2025
MDT
LISTED
NYSE
Medtronic announces cash dividend for third quarter of fiscal year 2026
News Preview
GALWAY, Ireland, Dec. 4, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, December 4, 2025, approved the company's cash dividend for the third quarter of fiscal year 2026 of $0.71 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
03.12.2025
MDT
LISTED
NYSE
Medtronic announces FDA clearance of Hugo™ robotic-assisted surgery system for urologic surgical procedures
News Preview
Hugo RAS system brings choice to the U.S., coupled with the full suite of Medtronic surgical offerings, ultimately creating a connected and integrated operating room today and into the future.GALWAY, Ireland, Dec. 3, 2025 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in surgical innovation, today announced the U.S. Food and Drug Administr...
Themefolio
Profiler
Peergroup
© PR Newswire
02.12.2025
MDT
LISTED
NYSE
Medtronic begins U.S. commercial launch of the MiniMed™ 780G system with the Instinct sensor, made by Abbott
News Preview
GALWAY, Ireland, Dec. 2, 2025 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the broad U.S. commercial launch of the MiniMed™ 780G system integrated with the Instinct sensor, made by Abbott and designed exclusively for MiniMed™ systems. Following U.S. FDA clearance of the system earlier this year...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
18.11.2025
MDT
LISTED
NYSE
Medtronic reports strong second quarter fiscal 2026 financial results, enterprise growth drivers accelerate momentum
News Preview
Cardiac Ablation Solutions growth of 71% on strength of pulsed field ablation (PFA) portfolio; Raising FY26 revenue and EPS guidance
GALWAY, Ireland, Nov. 18, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced fina...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
18.11.2025
MDT
LISTED
NYSE
Medtronic reports strong second quarter fiscal 2026 financial results, enterprise growth drivers accelerate momentum
News Preview
Cardiac Ablation Solutions growth of 71% on strength of pulsed field ablation (PFA) portfolio; Raising FY26 revenue and EPS guidance
GALWAY, Ireland, Nov. 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announc...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2025
MDT
LISTED
NYSE
Medtronic to announce financial results for its second quarter of fiscal year 2026
News Preview
GALWAY, Ireland, Nov. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, November 18, 2025, for its second quarter of fiscal year 2026, which ended on Friday, October 24, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
MDT
LISTED
NYSE
U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral™ renal denervation (RDN) system
News Preview
Symplicity blood pressure procedure is now covered for qualifying Medicare patients
GALWAY, Ireland, Oct. 28, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the Centers for Medicare & Medicaid Services (CMS) has released the final...
Themefolio
Profiler
Peergroup
© PR Newswire
26.10.2025
MDT
LISTED
NYSE
Three-year SPYRAL HTN-ON MED results show sustained, 18 mmHg office-based blood pressure reductions
News Preview
Long-term data shows significant and sustained blood pressure reductions in both office-based and 24-hour ambulatory blood pressure, reinforcing the durability, safety and effectiveness of the Symplicity™ blood pressure procedure in patients prescribed antihypertensive medications...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
MDT
LISTED
NYSE
Medtronic BrainSense™ Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions
News Preview
TIME Best Inventions honors extraordinary innovations changing lives
DUBLIN, Oct. 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that BrainSense™ Adaptive Deep Brain Stimulation (aDBS) – the world's...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
MDT
LISTED
NYSE
Medtronic initiates U.S. IDE clinical study evaluating Hugo™ robotic-assisted surgery system for gynecological procedures
News Preview
First procedures completed and enrollment underway in Embrace Gynecology study, furthering the company's progress to expand minimally invasive treatment options to patients in the United States
GALWAY, Ireland, Oct. 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced the start of the...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
MDT
LISTED
NYSE
Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes
News Preview
GALWAY, Ireland, Sept. 29, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has closed a registered public offering (the "Offering") of €750,000,000 principal amount of 2.950% senior notes due 2030 and €750,000,000 principal...
Themefolio
Profiler
Peergroup
© PR Newswire
19.09.2025
MDT
LISTED
NYSE
Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence
News Preview
The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks
GALWAY, Ireland, Sept. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced today that it has received U.S. Food and Drug Administration (FD...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
15.09.2025
MDT
LISTED
NYSE
Medtronic Announces Pricing of €1.5 Billion of Senior Notes
News Preview
GALWAY, Ireland, Sept. 15, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has priced an offering (the "Offering") of €750,000,000 principal amount of 2.950% senior notes due 2030 and €750,000,000 principal amount of 4.200% senior notes due 2045 (collective...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
MDT
LISTED
NYSE
Medtronic initiates global pivotal study of cardiac pacing in a new patient population
News Preview
Study to evaluate whether a new approach to pacing the heart can improve the lives of patients with heart failure with preserved ejection fraction (HFpEF) who have limited treatment options today
GALWAY, Ireland, Sept. 15, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the initiation of a...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
MDT
LISTED
NYSE
Study of Medtronic Hugo™ robotic-assisted surgery system in hernia repair meets safety and effectiveness endpoints
News Preview
First-ever investigational device exemption clinical study for robotic-assisted hernia repair in the U.S. presented at the American Hernia Society annual meeting
GALWAY, Ireland and NASHVILLE, Tenn., Sept. 4, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced results from the Enable Hernia Repair clinical study evaluating the performa...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
MDT
LISTED
NYSE
FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes
News Preview
GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones that broaden the MiniMed™ 780G system portfolio: clearance of the SmartGuard™ algorithm as an interoperable automated glycemic controller (iAGC), enab...
Themefolio
Profiler
Peergroup
© PR Newswire
29.08.2025
MDT
LISTED
NYSE
Medtronic executives to speak at upcoming investor conferences
News Preview
GALWAY, Ireland, Aug. 29, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the following investor conferences:
2025 Wells Fargo Healthcare Conference Thursday, September 4, 2025, at 8:00 a.m. EDT (7:00 a.m. CDT)Geoff Martha, Medtronic chairman and chief executive offic...
Themefolio
Profiler
Peergroup
© PR Newswire
29.08.2025
MDT
LISTED
NYSE
Medtronic executives to speak at upcoming investor conferences
News Preview
GALWAY, Ireland, Aug. 29, 2025 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the following investor conferences:
2025 Wells Fargo Healthcare Conference Thursday, September 4, 2025, at 8:00 a.m. EDT (7:00 a.m. CDT)Geoff Martha, Medtronic chairman and chief executive officer, and...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
MDT
LISTED
NYSE
Medtronic announces Board appointments and shareholder value creation initiatives to advance strategic priorities
News Preview
Experienced executives John Groetelaars and Bill Jellison appointed to the Board of Directors
Board forms new Growth and Operating committees to sharpen focus on the company's ongoing strategic portfolio management, operational execution and capital allocation
Plan to host Investor Day in 2026
Initiatives follow constructive engagement with Ellio...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
MDT
LISTED
NYSE
Medtronic announces Board appointments and shareholder value creation initiatives to advance strategic priorities
News Preview
Experienced executives John Groetelaars and Bill Jellison appointed to the Board of Directors
Board forms new Growth and Operating committees to sharpen focus on the company's ongoing strategic portfolio management, operational execution and capital allocation
Plan to host Investor Day in 2026
Initiatives follow constructive engagement with Ellio...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
MDT
LISTED
NYSE
Medtronic reports first quarter fiscal 2026 financial results
News Preview
11th quarter in a row of mid-single digit organic revenue growth;
Poised to accelerate growth
GALWAY, Ireland, Aug. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its first quarter (Q1) of fiscal year 2026 (FY26), which ended July 25, 2025.
Key Highlights...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
MDT
LISTED
NYSE
Medtronic reports first quarter fiscal 2026 financial results
News Preview
11th quarter in a row of mid-single digit organic revenue growth;Poised to accelerate growth
GALWAY, Ireland, Aug. 19, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its first quarter (Q1) of fiscal year 2026 (FY26), which ended July 25, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
14.08.2025
MDT
LISTED
NYSE
Medtronic announces cash dividend for second quarter of fiscal year 2026
News Preview
GALWAY, Ireland, Aug. 14, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 14, 2025, approved the company's cash dividend for the second quarter of fiscal year 2026 of $0.71 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 202...
Themefolio
Profiler
Peergroup
© PR Newswire
05.08.2025
MDT
LISTED
NYSE
Medtronic to announce financial results for its first quarter of fiscal year 2026
News Preview
GALWAY, Ireland, Aug. 5, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, August 19, 2025, for its first quarter of fiscal year 2026, which ended on Friday, July 25, 2025,
A news release containing summary financial information will be issued at ap...
Themefolio
Profiler
Peergroup
© PR Newswire
05.08.2025
MDT
LISTED
NYSE
Medtronic to announce financial results for its first quarter of fiscal year 2026
News Preview
GALWAY, Ireland, Aug. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, August 19, 2025, for its first quarter of fiscal year 2026, which ended on Friday, July 25, 2025,
A news release containing summary financial information will be issue...
Themefolio
Profiler
Peergroup
© PR Newswire
21.07.2025
MDT
LISTED
NYSE
Medtronic secures CE Mark for MiniMed™ 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy, and for type 2 diabetes
News Preview
GALWAY, Ireland, July 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in medical technology, today announced CE (Conformité Européenne) Mark in Europe to expand indications of the MiniMed™ 780G system for use by individuals aged 2 years and older, during pregnancy, as well as type 2 insulin-requiring diabetes. To gain CE Mark...
Themefolio
Profiler
Peergroup
© PR Newswire
08.07.2025
MDT
LISTED
NYSE
Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company
News Preview
GALWAY, Ireland, July 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of MiniMed, in advance of its intended separation into a standalone, public company. Effective July 14, 2025, Chad will be responsible for overseeing th...
Themefolio
Profiler
Peergroup
© PR Newswire
23.06.2025
MDT
LISTED
NYSE
Medtronic Board appoints Dr. Joon Lee as a new director
News Preview
GALWAY, Ireland, June 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an independent director, effective June 18, 2025. Dr. Lee will serve on the Science and Technology Committee and Comp...
Themefolio
Profiler
Peergroup
© PR Newswire
12.06.2025
MDT
LISTED
NYSE
Medtronic announces MiniMed as name for planned New Diabetes Company
News Preview
GALWAY, Ireland, June 12, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following the intended separation. The name honors the company's roots, reflecting its original name prior to its acquisition by Medtronic in 2001, and a deep 40-year...
Themefolio
Profiler
Peergroup
© PR Newswire
12.06.2025
MDT
LISTED
NYSE
Medtronic announces MiniMed as name for planned New Diabetes Company
News Preview
GALWAY, Ireland, June 12, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following the intended separation. The name honors the company's roots, reflecting its original name prior to its acquisition by Medtronic in 2001, and a deep...
Themefolio
Profiler
Peergroup
© PR Newswire
23.05.2025
MDT
LISTED
NYSE
Medtronic chairman and CEO Geoff Martha to speak at Bernstein's Strategic Decisions Conference
News Preview
GALWAY, Ireland, May 23, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate in Bernstein's 41st Strategic Decisions Conference on Thursday, May 29, 2025.
Geoff Martha, Medtronic chairman and chief executive officer, will make a formal presentation beginning at 11:00 a.m. EDT (10:...
Themefolio
Profiler
Peergroup
© PR Newswire
23.05.2025
MDT
LISTED
NYSE
Medtronic chairman and CEO Geoff Martha to speak at Bernstein's Strategic Decisions Conference
News Preview
GALWAY, Ireland, May 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate in Bernstein's 41st Strategic Decisions Conference on Thursday, May 29, 2025.
Geoff Martha, Medtronic chairman and chief executive officer, will make a formal presentation beginning at 11:00 a.m. E...
Themefolio
Profiler
Peergroup
© PR Newswire
21.05.2025
MDT
LISTED
NYSE
Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase
News Preview
Building momentum in key franchises including Pulsed Field Ablation, TAVR, Cardiac Rhythm Management, Diabetes, Spine, and Neuromodulation
GALWAY, Ireland, May 21, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its fourth quarter (Q4) and fiscal year 2025 (FY25), which ende...
Themefolio
Profiler
Peergroup
© PR Newswire
21.05.2025
MDT
LISTED
NYSE
Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase
News Preview
Building momentum in key franchises including Pulsed Field Ablation, TAVR, Cardiac Rhythm Management, Diabetes, Spine, and Neuromodulation
GALWAY, Ireland, May 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its fourth quarter (Q4) and fiscal year 2025 (FY25), whi...
Themefolio
Profiler
Peergroup
© PR Newswire
21.05.2025
MDT
LISTED
NYSE
Medtronic announces intent to separate Diabetes business
News Preview
Enables intense focus on highest margin growth drivers where Medtronic has leading core competencies
Leading, scaled, direct-to-consumer Diabetes business poised to become standalone company; only company with a complete ecosystem to address intensive insulin management
GALWAY, Ireland, May 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a gl...
Themefolio
Profiler
Peergroup
© PR Newswire
21.05.2025
MDT
LISTED
NYSE
Medtronic announces intent to separate Diabetes business
News Preview
Enables intense focus on highest margin growth drivers where Medtronic has leading core competencies
Leading, scaled, direct-to-consumer Diabetes business poised to become standalone company; only company with a complete ecosystem to address intensive insulin management
GALWAY, Ireland, May 21, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global le...
Themefolio
Profiler
Peergroup
© PR Newswire
08.05.2025
MDT
LISTED
NYSE
Medtronic to announce financial results for its fourth quarter and full fiscal year 2025
News Preview
GALWAY, Ireland, May 7, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2025 on Wednesday, May 21, 2025. A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be availa...
Themefolio
Profiler
Peergroup
© PR Newswire
08.05.2025
MDT
LISTED
NYSE
Medtronic to announce financial results for its fourth quarter and full fiscal year 2025
News Preview
GALWAY, Ireland, May 7, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2025 on Wednesday, May 21, 2025. A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at...
Themefolio
Profiler
Peergroup
© PR Newswire
07.05.2025
MDT
LISTED
NYSE
New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women
News Preview
Star Jones, award winning television personality & women's heart health advocate, helps kick off heart health conversations this Mother's Day with the Medtronic 'Letter to My Mother' campaign
GALWAY, Ireland, May 7, 2025 /PRNewswire/ -- A new Medtronic-sponsored survey of women ages 30-50 reveals a significant gap in awareness and discussion...
Themefolio
Profiler
Peergroup
© PR Newswire
27.04.2025
MDT
LISTED
NYSE
Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients
News Preview
One-year clinical trial data for the next-generation, investigational, Sphere-360™ single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal AfibDual-energy (RF/PF), focal Sphere-9™ catheter demonstrates efficacy for linear ablation in persistent AFibMedtronic continues legacy of leadership in innovation,...
Themefolio
Profiler
Peergroup
© PR Newswire
26.04.2025
MDT
LISTED
NYSE
Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system
News Preview
Largest multi-center prospective Investigational Device Exemption (IDE) study for multi-port robotic-assisted urologic surgery in the U.S. presented as a late-breaker at the American Urologic Association annual meeting Company confirms Hugo RAS system submission to the U.S. Food and Drug Administration
GALWAY, Ireland and LAS VEGAS, April 26, 202...
Themefolio
Profiler
Peergroup
© PR Newswire
25.04.2025
MDT
LISTED
NYSE
Medtronic receives FDA approval for smallest-diameter, lumenless defibrillation lead, the OmniaSecure™ lead and announces investigational clinical study results
News Preview
Adding to the Medtronic portfolio of catheter-based lead solutions, the novel OmniaSecure defibrillation lead allows for precise delivery and placement in the right ventricle
Heart Rhythm 2025: Late-breaking clinical study results evaluating the OmniaSecure lead for investigational use in the LBBAP location show high defibrillation success
GALWA...
Themefolio
Profiler
Peergroup
© PR Newswire
24.04.2025
MDT
LISTED
NYSE
Medtronic advances Abbott CGM partnership with FDA submission of interoperable insulin pump
News Preview
GALWAY, Ireland, April 24, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has submitted 510(k) applications to the U.S. Food and Drug Administration (FDA) seeking clearance for an interoperable pump. FDA clearance of this pump would pave the way for system integration with a continuous...
Themefolio
Profiler
Peergroup
© PR Newswire
19.04.2025
MDT
LISTED
NYSE
New Simplera Sync™ sensor for the MiniMed™ 780G System now FDA approved
News Preview
Latest approval expands Medtronic CGM portfolio in the U.S.
GALWAY, Ireland, April 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for the Simplera Sync™ sensor for use with the MiniMed™ 780G system. With this approval, the MiniMed™...
Themefolio
Profiler
Peergroup
© PR Newswire
30.03.2025
MDT
LISTED
NYSE
Medtronic Evolut™ TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients
News Preview
GALWAY, Ireland and CHICAGO, March 30, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Data shows, versus surgery, the Evolut™ transcatheter aortic valve replacement (TAVR) system delivers a numerically lower rate of...
Themefolio
Profiler
Peergroup
© PR Newswire
09.03.2025
MDT
LISTED
NYSE
SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients
News Preview
CRT 2025 Late Breaking Science features largest head-to-head randomized control TAVR trial to primarily enroll women using the two most widely used global TAVR devices
GALWAY, Ireland and WASHINGTON, March 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMall...
Themefolio
Profiler
Peergroup
© PR Newswire
06.03.2025
MDT
LISTED
NYSE
Medtronic announces cash dividend for fourth quarter of fiscal year 2025
News Preview
GALWAY, Ireland, March 6, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, March 6, 2025, approved the company's cash dividend for the fourth quarter of fiscal year 2025 of $0.70 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2024...
Themefolio
Profiler
Peergroup
© PR Newswire
24.02.2025
MDT
LISTED
NYSE
Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's
News Preview
New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever
GALWAY, Ireland, Feb. 24, 2025 /PRNewswire/ -- For the one million people diagnosed with Parkinson's disease in the United States1, Medtronic plc (NYSE:MDT), a global leader in healt...
Themefolio
Profiler
Peergroup
© PR Newswire
18.02.2025
MDT
LISTED
NYSE
Medtronic reports third quarter fiscal 2025 financial results
News Preview
Delivering durable revenue growth with strong earnings power; strength in Pulsed Field Ablation, Pacing, Structural Heart, Diabetes, and Neuromodulation
GALWAY, Ireland, Feb. 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced financial results for its third quarter (Q3) of fiscal year 2025 (FY25), which ended January 24, 2025.
Key...
Themefolio
Profiler
Peergroup
© PR Newswire
18.02.2025
MDT
LISTED
NYSE
Medtronic reports third quarter fiscal 2025 financial results
News Preview
Delivering durable revenue growth with strong earnings power; strength in Pulsed Field Ablation, Pacing, Structural Heart, Diabetes, and Neuromodulation
GALWAY, Ireland, Feb. 18, 2025 /CNW/ -- Medtronic plc (NYSE: MDT) today announced financial results for its third quarter (Q3) of fiscal year 2025 (FY25), which ended January 24, 2025.
Key Highli...
Themefolio
Profiler
Peergroup
© PR Newswire
05.02.2025
MDT
LISTED
NYSE
Medtronic to announce financial results for its third quarter of fiscal year 2025
News Preview
GALWAY, Ireland, Feb. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2025 on Tuesday, February 18, 2025. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available...
Themefolio
Profiler
Peergroup
© PR Newswire
05.02.2025
MDT
LISTED
NYSE
Medtronic to announce financial results for its third quarter of fiscal year 2025
News Preview
GALWAY, Ireland, Feb. 5, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2025 on Tuesday, February 18, 2025. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at htt...
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2025
MDT
LISTED
NYSE
Medtronic appoints Thierry Piéton as Chief Financial Officer
News Preview
GALWAY, Ireland, Jan. 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that Thierry Piéton has been appointed Chief Financial Officer for the company, effective March 3, 2025. He will report to Medtronic Chairman and Chief Executive Officer Geoff Martha and will join the Medtronic Execu...
Themefolio
Profiler
Peergroup
© PR Newswire
13.01.2025
MDT
LISTED
NYSE
Medtronic announces CMS national coverage analysis for Symplicity™ Spyral Renal Denervation System
News Preview
National coverage analysis is the first-of-its kind for a minimally invasive, interventional treatment for high blood pressureMilestone is supported by large public health need and robust, long-term data from the SPYRAL-HTN global clinical programGALWAY, Ireland, Jan. 13, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthca...
Themefolio
Profiler
Peergroup
© PR Newswire
13.01.2025
MDT
LISTED
NYSE
Medtronic achieves CE Mark approval for BrainSense™ Adaptive deep brain stimulation and Electrode Identifier, a groundbreaking advance in personalized, sensing-enabled care for people with Parkinson's through innovative brain-computer interface technology
News Preview
European approval introduces the world's only closed-loop DBS system with real-time, self-adjusting brain stimulation for people with Parkinson's disease
GALWAY, Ireland, Jan. 13, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, announced today CE (Conformité Européenne) Mark approval in the European Union...
Themefolio
Profiler
Peergroup
© PR Newswire
06.01.2025
MDT
LISTED
NYSE
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
News Preview
GALWAY, Ireland, Jan. 6, 2025 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 43rd annual J.P. Morgan healthcare conference on Monday, January 13, 2025.
Geoff Martha, Medtronic chairman and chief executive officer, will make a formal presentation and answer questions on the c...
Themefolio
Profiler
Peergroup
© PR Newswire
06.01.2025
MDT
LISTED
NYSE
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
News Preview
GALWAY, Ireland, Jan. 6, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 43rd annual J.P. Morgan healthcare conference on Monday, January 13, 2025.
Geoff Martha, Medtronic chairman and chief executive officer, will make a formal presentation and answer questions o...
Themefolio
Profiler
Peergroup
© PR Newswire
05.12.2024
MDT
LISTED
NYSE
Medtronic announces cash dividend for third quarter of fiscal year 2025
News Preview
GALWAY, Ireland, Dec. 5, 2024 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, December 5, 2024, approved the company's cash dividend for the third quarter of fiscal year 2025 of $0.70 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 202...
Themefolio
Profiler
Peergroup
© PR Newswire
20.11.2024
MDT
LISTED
NYSE
Medtronic receives FDA clearance for new InPen™ app, paving the way for its Smart MDI system launch with Simplera™ CGM
News Preview
New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses.
GALWAY, Ireland, Nov. 20, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clear...
Themefolio
Profiler
Peergroup
© PR Newswire
19.11.2024
MDT
LISTED
NYSE
Medtronic reports second quarter fiscal 2025 financial results
News Preview
Delivering on commitments, executing ahead of expectations, and raising guidance
Innovation driving sustained growth across many franchises: TAVR, PFA, Leadless Pacemakers, Diabetes, Spine, and Neuromodulation
GALWAY, Ireland, Nov. 19, 2024 /CNW/ -- Medtronic plc (NYSE: MDT) today announced financial results for its second quarter (Q2) of fiscal...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
